Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Characteristic of a drug carrier for hepatocellular carcinoma (HCC)-selective targeting

Not Accessible

Your library or personal account may give you access

Abstract

Galactose can be specifically recognized by ASGPR. PEG-Gal-COS-CYPATE was constructed to target the drug to HCC cells. Due to steric hindrance of PEG, drugs will not bind to the normal liver cells to avoid damage.

© 2015 Optical Society of America

PDF Article
More Like This
EGFR Targeting Photoacoustic Probe for Hepatocellular Carcinoma Imaging in Vivo

Quan Zhou, Zhao Li, Juan Zhou, Bishnu P. Joshi, Gaoming Li, Xiyu Duan, Rork Kuick, Scott R. Owens, and Thomas D. Wang
CTh2A.6 Cancer Imaging and Therapy (Cancer) 2016

A novel folate-receptor targeted indocyanine green nanoprobe for in vivo photoacoustic/fluorescence dual-modality imaging of breast carcinoma

Chengbo Liu, Huina Wang, and Liang Song
OW3D.2 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2015

A Quantitative Assessment of Hepatocellular Carcinoma Grading using Multiphoton Microscopy

Hongxin Lin, Ning Zuo, and Shuangmu Zhuo
W3A.69 International Conference on Photonics and Imaging in Biology and Medicine (PIBM) 2017

Poster Presentation

Media 1: PDF (567 KB)     
Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.